Latest 10-K annual reports

Abeona Therapeutics Inc. reports FDA approval for ZEVASKYN, generating significant revenue from a Priority Review Voucher sale, while continuing to advance its gene therapy pipeline.

PSQ Holdings, Inc. announced a strategic pivot to focus solely on its Financial Technology segment, reporting reduced net losses for 2025, but faces a NYSE delisting notice due to non-compliance with listing standards.

Bicycle Therapeutics reported increased net losses in 2025 and announced a strategic reprioritization of its clinical pipeline, including discontinuing certain trials and a 30% workforce reduction, to focus on next-generation therapeutics.

Monte Rosa Therapeutics reported significant progress in its molecular glue degrader pipeline, including positive clinical data for MRT-2359 and MRT-8102, and strengthened its financial position with a $323.8 million capital raise.

Clene Inc. reports strong clinical data for its lead drug candidate CNM-Au8 in ALS, paving the way for an accelerated FDA approval pathway by mid-2026, despite ongoing financial challenges.

X4 Pharmaceuticals details a strategic pivot towards chronic neutropenia, significant capital raises, and management changes in its 2025 annual report.

BM Acquisition Corp., a SPAC targeting Southeast Asian businesses, reported a net loss and significant working capital deficit for 2025, raising substantial doubt about its ability to continue as a going concern, further complicated by its IPO not yet being consummated despite its registration statement being effective since September 2025.

Primis Financial Corp. reported a significant turnaround in 2025, achieving $61 million in net income and $2.49 EPS, driven by strategic business line growth and a sale-leaseback transaction.

Spirit Aviation Holdings, Inc. reports a substantial net loss of $2.76 billion for 2025 and warns of liquidation risk, with no recovery expected for common stockholders in its ongoing Chapter 11 proceedings.

Microvast Holdings, Inc. reported a 12.6% increase in revenue to $427.5 million for fiscal year 2025, alongside a significant reduction in net loss, but continues to face substantial doubt about its ability to continue as a going concern.

Investors Title Company reported a significant increase in net income and total revenues for the fiscal year ended December 31, 2025, driven by increased real estate activity and strategic rate adjustments.

Pangaea Logistics Solutions reported an 18% revenue increase to $632 million in 2025 driven by fleet expansion, but net income declined 36.5% amid lower market rates and increased operating costs.

Agenus Inc. reports significantly reduced net losses and improved cash flow in 2025, bolstered by a strategic manufacturing facility sale and promising clinical data for its lead immunotherapy.

Green Dot Corporation posted a significant net loss in 2025, driven by increased operating expenses and equity method losses, as it pursues a strategic merger and sale of its Payments Business.

Rallybio Corporation announces a definitive merger agreement with Candid Therapeutics, shifting its strategic focus to T-cell engager therapeutics and monetizing legacy assets through Contingent Value Rights.

MetroCity Bankshares, Inc. reported a 6.2% increase in net income for 2025, driven by the successful acquisition of First IC Corporation and organic loan growth, despite rising noninterest expenses.

PLAYSTUDIOS, Inc. reported a significant 18.8% decrease in net revenue for the fiscal year ended December 31, 2025, primarily driven by declines in virtual currency and advertising revenue in its playGAMES segment.

Cantor Equity Partners III, Inc. (CAEP) files its 2025 Annual Report, detailing its proposed business combination with AIR Limited and outlining financial status and operational risks.

Tavia Acquisition Corp. reports on its 2025 financial performance and ongoing search for a business combination, focusing on new energy, circular economy, and food technologies.

Consolidated Water Co. Ltd. reported a decrease in overall revenue for 2025 but saw improved gross profit margins and strong performance in its retail and manufacturing segments, alongside ongoing challenges in license negotiations and project delays.

Artesian Resources Corporation announced robust financial results for 2025, driven by customer growth and rate increases, while also securing a new $10 million loan for its Maryland subsidiary.

Quartzsea Acquisition Corporation, a SPAC, reported its fiscal year 2025 results, including a net income of $510,959, and announced a definitive merger agreement with Broadway Technology Inc., a PET cups and lids manufacturer, while also disclosing substantial doubt about its ability to continue as a going concern.

VAALCO Energy reported a net loss of $41.4 million in 2025, primarily due to an impairment loss on Canadian assets and lower revenues, despite strategic acquisitions and ongoing development programs in Africa.

Ampco-Pittsburgh Corporation reported a significant net loss of $66.1 million for 2025, primarily driven by the deconsolidation of its UK subsidiary and increased asbestos-related liabilities, despite some revenue growth.

Western New England Bancorp reports increased net income and improved asset quality for fiscal year 2025, as detailed in its amended annual report.

American Vanguard Corporation reported a reduced net loss and improved gross profit margins in 2025, driven by its business improvement plan, despite a 6% decline in net sales due to challenging agricultural market conditions.

BayCom Corp announced a 1.3% increase in net income to $23.9 million for 2025, driven by higher net interest income and improved efficiency, despite an increase in nonperforming assets.

Assertio Holdings reports a comprehensive loss of $30.4 million in 2025, driven by strategic divestitures and ROLVEDON integration efforts, despite increased ROLVEDON sales.

Investar Holding Corporation reported a 7.9% increase in net income available to common shareholders for fiscal year 2025, driven by margin expansion and strategic acquisition activity.

Bleichroeder Acquisition Corp. II, a SPAC, has entered into a definitive merger agreement with French quantum computing company Pasqal Holding SAS, targeting a second-half 2026 closing.